Modified virus takes on bile duct cancer in new trial
Disease control
Not yet recruiting
This study tests a new treatment called VG2025 for people with advanced bile duct cancer that has spread. VG2025 is a modified virus designed to infect and kill cancer cells while boosting the immune system. The trial will enroll 30 adults to see if the treatment can shrink tumor…
Phase: PHASE2 • Sponsor: Virogin Biotech Ltd. • Aim: Disease control
Last updated May 08, 2026 12:04 UTC